rituximab,obinutuzumab
biogen,roche
['obinu', 'follicular', 'lymsm', 'lymphoma']
congress #eha22 | william townsend presented final analysis results from the gallium phase iii study of obinutuzumab+chemo in pts with treatment na ve follicular lymphoma. n=1202, median follow-up=8 yrs, improved pfs in subgroups, no new safety signals #lymsm #lymphoma 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm